Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 21, Pages 11429
Publisher
MDPI AG
Online
2021-10-25
DOI
10.3390/ijms222111429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathophysiology of Skin Resident Memory T Cells
- (2021) Yoshiki Tokura et al. Frontiers in Immunology
- Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo
- (2021) Mala Singh et al. CYTOKINE
- Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective
- (2021) Katia Boniface et al. Frontiers in Immunology
- Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation
- (2020) Melpone Komnitski et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- New onset vitiligo in a patient with hidradenitis suppurativa treated with adalimumab
- (2020) Kevin Phan et al. Dermatologic Therapy
- Vitiligo: A Review
- (2020) Christina Bergqvist et al. DERMATOLOGY
- Drug‐induced vitiligo: a case/non‐case study in Vigibase ® , the WHO pharmacovigilance database
- (2020) Norah Anthony et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child
- (2020) Brianna Olamiju et al. PEDIATRIC DERMATOLOGY
- Decreased suppression of CD8 + and CD4 + T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins
- (2020) Prashant S. Giri et al. EXPERIMENTAL DERMATOLOGY
- Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
- (2020) David Rosmarin et al. LANCET
- New-Onset Vitiligo During Treatment with Secukinumab: Report of Two Cases and Review of the Literature
- (2020) Lula María Nieto-Benito et al. CLINICAL DRUG INVESTIGATION
- Investigation of the Role of Interleukin 6 in Vitiligo Pathogenesis
- (2020) Mala Singh et al. IMMUNOLOGICAL INVESTIGATIONS
- Efficacy and safety of oral simvastatin in the treatment of patients with vitiligo
- (2020) Shiyu Zhang et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Levels of TNF-α, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo
- (2020) Ebru Karagün et al. Aging Male
- An update on Vitiligo pathogenesis
- (2020) Julien Seneschal et al. Pigment Cell & Melanoma Research
- Elevated serum level of interleukin‐15 in vitiligo patients and its correlation with disease severity but not activity
- (2020) Mona A. Atwa et al. Journal of Cosmetic Dermatology
- Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1/17 cells
- (2019) Li Zhang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity
- (2019) Yinghan Wang et al. MEDICAL SCIENCE MONITOR
- A pilot study of 2% tofacitinib cream with narrow-band UVB for the treatment of facial vitiligo
- (2019) Jacqueline McKesey et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL‐17A is not a treatment target in progressive vitiligo
- (2019) Reinhart Speeckaert et al. Pigment Cell & Melanoma Research
- Vitiligo in a patient receiving infliximab for chronic plaque psoriasis
- (2019) Xiya Lu et al. Dermatologic Therapy
- miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment
- (2019) Mengyun Su et al. EXPERIMENTAL CELL RESEARCH
- Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo
- (2019) Shuli Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Open‐label pilot study of tofacitinib 2% for the treatment of refractory vitiligo
- (2019) P. Mobasher et al. BRITISH JOURNAL OF DERMATOLOGY
- Vitiligo remitting with tocilizumab
- (2018) C.B. Bunker et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
- (2018) Jillian M. Richmond et al. Science Translational Medicine
- Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease
- (2018) Sushama Sushama et al. Journal of Cosmetic Dermatology
- Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy
- (2018) Sa Rang Kim et al. JAMA Dermatology
- PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin
- (2018) Xiao Miao et al. Scientific Reports
- Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo
- (2018) Jillian M. Richmond et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- New onset vitiligo following commencement of infliximab in Crohn disease
- (2017) Raphael P. Luber et al. INTERNAL MEDICINE JOURNAL
- Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo
- (2017) Mario Vaccaro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients
- (2017) Zhiwei Shang et al. JOURNAL OF DERMATOLOGY
- Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease
- (2017) Jillian M. Richmond et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
- (2017) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- New discoveries in the pathogenesis and classification of vitiligo
- (2017) Michelle Rodrigues et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
- (2017) Brooke Rothstein et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Reduced immunohistochemical expression of adhesion molecules in vitiligo skin biopsies
- (2017) Adriane Reichert Faria et al. PATHOLOGY RESEARCH AND PRACTICE
- Interleukin-22 participates in the inflammatory process of vitiligo
- (2017) Jinjin Dong et al. Oncotarget
- Vitiligo and Autoimmune Thyroid Disorders
- (2017) Enke Baldini et al. Frontiers in Endocrinology
- IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo
- (2016) Mario Vaccaro et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Oxidative stress, microRNAs and cytosolic calcium homeostasis
- (2016) Alessandra Magenta et al. CELL CALCIUM
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- (2016) John E. Harris et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases
- (2016) L. Méry-Bossard et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo
- (2015) L Yang et al. ACTA DERMATO-VENEREOLOGICA
- Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?
- (2015) Joon Min Jung et al. Annals of Dermatology
- Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo
- (2015) K.C. Webb et al. BRITISH JOURNAL OF DERMATOLOGY
- Vitiligo
- (2015) Khaled Ezzedine et al. LANCET
- Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases
- (2015) Roberta Colucci et al. Oxidative Medicine and Cellular Longevity
- Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development
- (2015) Li Zhou et al. Pigment Cell & Melanoma Research
- Tofacitinib Citrate for the Treatment of Vitiligo
- (2015) Brittany G. Craiglow et al. JAMA Dermatology
- Plasma levels of interleukin-17, interleukin-23, and transforming growth factor-β in Sudanese patients with vitiligo: A case-control study
- (2015) AliMalik Osman et al. INDIAN JOURNAL OF DERMATOLOGY
- Segmental vitiligo after infliximab use for rheumatoid arthritis - A case report
- (2014) Clarissa Luiza Dalla Bernardina Carvalho et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Inflammasome activation and vitiligo/nonsegmental vitiligo progression
- (2014) J. Marie et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin-33 affects cytokine production by keratinocytes in vitiligo
- (2014) P. Li et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo
- (2014) Mario Vaccaro et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Melanocytes as Instigators and Victims of Oxidative Stress
- (2014) Laurence Denat et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Impaired Activation of the Nrf2-ARE Signaling Pathway Undermines H 2 O 2 -Induced Oxidative Stress Response: A Possible Mechanism for Melanocyte Degeneration in Vitiligo
- (2014) Zhe Jian et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interferon-γ Induces Senescence in Normal Human Melanocytes
- (2014) Suiquan Wang et al. PLoS One
- Association of Neuropeptide Y (NPY), Interleukin-1B (IL1B) Genetic Variants and Correlation of IL1B Transcript Levels with Vitiligo Susceptibility
- (2014) Naresh C. Laddha et al. PLoS One
- CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
- (2014) M. Rashighi et al. Science Translational Medicine
- The Role of Tumor Necrosis Factor-α in the Pathogenesis of Vitiligo
- (2013) Carlos R. Camara-Lemarroy et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Classification of segmental vitiligo on the trunk
- (2013) N. van Geel et al. BRITISH JOURNAL OF DERMATOLOGY
- Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo
- (2013) Matteo Bordignon et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo
- (2013) Shilpak Chatterjee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells
- (2013) Cara N Skon et al. NATURE IMMUNOLOGY
- NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1 processing via the NLRP1 inflammasome
- (2013) C. B. Levandowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Subtoxic levels hydrogen peroxide-induced expression of interleukin-6 by epidermal melanocytes
- (2012) Lei Yao et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Activation of the Unfolded Protein Response in Vitiligo: The Missing Link?
- (2012) Thierry Passeron et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin
- (2012) John E. Harris et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters
- (2011) Nancy H. Kim et al. Cutaneous and Ocular Toxicology
- TNFα: Activator or inhibitor of regulatory T cells?
- (2011) Jérôme Biton et al. JOINT BONE SPINE
- IFN-γ, IL-21, and IL-10 Co-Expression in Evolving Autoimmune Vitiligo Lesions of Smyth Line Chickens
- (2011) Fengying Shi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vitiligo in a patient receiving infliximab for refractory ulcerative colitis
- (2011) Waleed A. Ismail et al. Arab Journal of Gastroenterology
- A Patient with Psoriasis and Vitiligo Treated with Etanercept
- (2010) Anna Campanati et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1
- (2010) Mari-Anne Philips et al. BMC Medical Genetics
- Role of interleukin-17 in the pathogenesis of vitiligo
- (2010) D. A. Bassiouny et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Interleukins 1α and 1β secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens
- (2010) Olga Kholmanskikh et al. INTERNATIONAL JOURNAL OF CANCER
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
- (2009) Xiaoyu Hu et al. IMMUNITY
- Cutting Edge: The Th1 Response Inhibits the Generation of Peripheral Regulatory T Cells
- (2009) David Caretto et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started